Antibody Drug Conjugate Market Analysis Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Antibody Drug Conjugate Market
Antibody Drug Conjugate Market Analysis: By Phase (Clinical, Pre-Clinical) By Availability (Approved Drugs, Pipeline Drugs) and By Geography (Europe, APAC, North America and ROW)– With Forecast (2018-2023)
Report Code : HCR 0152
Updated Date: 18 October, 2018  

1. Antibody Drug Conjugate Market - Overview
1.1. Definitions and Scope
2. Antibody Drug Conjugate Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Antibody Drug Conjugate Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Antibody Drug Conjugate Market – Startup companies Scenario
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Antibody Drug Conjugate Market – Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Antibody Drug Conjugate Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Antibody Drug Conjugate Market - Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Antibody Drug Conjugate Market – By Phase (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Clinical
8.3.2. Pre-Clinical
9. Antibody Drug Conjugate Market – By Availability (Market Size -$Million / $Billion)
9.1. Approved Drugs
9.1.1. Adcetris
9.1.2. Kadcyla
9.2. Pipeline Drugs
9.2.1. T-DM1
9.2.2. CMC-544
9.2.3. CDX-011
9.2.4. SAR3419
9.2.5. Others
10. Antibody Drug Conjugate - By Geography (Market Size -$Million / $Billion)
10.1. Antibody Drug Conjugate Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Antibody Drug Conjugate - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Antibody Drug Conjugate - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Antibody Drug Conjugate – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Antibody Drug Conjugate Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Antibody Drug Conjugate Market – Industry / Segment Competition landscape
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practices for companies
13. Antibody Drug Conjugate Market – Key Company List by Country
14. Antibody Drug Conjugate Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. ImmunoGen
14.3. Immunomedics
14.4. Seattle Genetics   
14.5. Bayer HealthCare AG
14.6. Pfizer Inc
14.7. Roche/Genentech
14.8. Novartis
14.9. Heidelberg Pharma
14.10. Oxford BioTherapeutics
14.11. Agensys, Inc
14.12. Company 11
14.13. Company 12
14.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Antibody Drug Conjugate Market - Appendix
15.1. Abbreviations
15.2. Sources
16. Antibody Drug Conjugate Market - Methodology
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll